Industry Trend Analysis
The biochips market is expected to be around $26 billion by 2025. Increasing advancements in personalized medicine, rising demand for miniaturization of clinical and biological test systems, increase in research activities related to proteomics and genomics, advancements in designing protein arrays and rising applications of biochips in accelerated drug development are some of the major factors driving the growth of global biochips market. Moreover, increase in the incidence of chronic diseases such as cancer has prompted development of biochips to be used for diagnosing certain variants of these diseases and for controlling disease progression. According to the National Cancer Institute under the U.S. Department of Health and Human Services, between 2012 and 2030, new cancer cases around the world are expected to increase by 50% from 14 million to 21 million. With such high incidence of cancer, the related research efforts are expected to significantly increase thus favorably contributing to the growth of biochips market during the forecast period. However, factors such as high cost of biochip instrumentation and unclear regulatory guidelines can hamper the growth of this biochips market during the forecast period.
Product Outlook and Trend Analysis
DNA chips segment dominated the global biochips market in 2016. This market dominance can be attributed to the extensive adoption of DNA chips for detection and diagnosis of various genetic diseases along with increased focus on research related to next-generation sequencing and genomics. With rapid adoption of diagnostic lab-on-a-chip (LOAC) and DNA analysis for point-of-care diagnostics and drug discovery applications, the global biochips market will experience robust growth during the forecast period.
Application Outlook and Trend Analysis
Drug discovery and development segment held a major share of the biochips market in 2016 as biochips are being increasingly adopted for developing highly specific drug molecules and new chemical entity (NCE) drugs for the treatment of various diseases. Biochips can considerably reduce the cost of drug discovery and aid in improving drug safety and hence are being widely adopted by biotechnology and pharmaceutical companies for drug discovery applications.
Fabrication Technology Outlook and Trend Analysis
Two major technologies used for fabricating biochips involve microarrays and microfluidics. A microarray is a silicon chip or a glass slide which consists of an array of molecules such as polypeptides, clones, oligonucleotides and antibodies. These molecules used are primarily used for gene expression and simultaneous examination of relationship between different genes. Microfluidics is a technology which involves micro-channels segmented on glass or a silicon substrate. This technology has various biomedical applications that include immunoassays, drug discovery, capillary electrophoresis and cell biology research.
Regional Trend Analysis
North America dominated the biochips market in 2016 owing to the presence of highly advanced healthcare research infrastructure, increasing geriatric population and rising prevalence of different lifestyle disorders such as cardiac disorders, asthma and diabetes. Asia-Pacific biochips market is expected to grow with the highest CAGR during the forecast period as a result of increasing expenditure related to research activities involving proteomics, genomics and next-generation sequencing in emerging countries such as China and India.
The key players operating in the global biochips market focus on strategic collaborations, acquisitions and mergers in order to strengthen their product portfolio as well as their product development activities. Some of the key players in this market are Thermo Fisher Scientific, Inc., Illumina, Inc., PerkinElmer Inc., Agilent Technologies, Inc., Fluidigm Corporation, General Electric Company, Bio-Rad Laboratories Inc., bioMérieux SA, and Cellix Ltd.
With high prevalence of cancer and other chronic diseases worldwide, the need for advanced drug development alternatives is increasing significantly in all parts of the world. Emerging markets such as Asia-Pacific are expected to offer significant growth opportunities for the global biochips market in coming years as expenditure on advanced research is rising considerably in developing countries such as China and India.
Biochips Market Segmentation:
Drug Discovery & Development
Cancer Diagnosis & Treatment
IVD and POC
By Fabrication Technology:
By End User:
Academic & Research Institutes
Hospitals and Diagnostics Centers
Biotechnology and Pharmaceutical Companies
Rest of Europe
Rest of Asia-Pacific
Rest of the World
United Arab Emirates
Some of the key questions answered by the report are:
What was the market size in 2016 and forecast from 2017 to 2025?
What will be the industry market growth from 2017 to 2025?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?